NO20083333L - Fremgangsmater for forbedring av farmakokinetikken til HIV-integraseinhibitorer - Google Patents
Fremgangsmater for forbedring av farmakokinetikken til HIV-integraseinhibitorerInfo
- Publication number
- NO20083333L NO20083333L NO20083333A NO20083333A NO20083333L NO 20083333 L NO20083333 L NO 20083333L NO 20083333 A NO20083333 A NO 20083333A NO 20083333 A NO20083333 A NO 20083333A NO 20083333 L NO20083333 L NO 20083333L
- Authority
- NO
- Norway
- Prior art keywords
- hiv integrase
- pharmacokinetics
- improving
- methods
- integrase inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
Oppfinnelsen tilveiebringer fremgangsmåter for forbedring av farmakokinetikken til en HIVintegraseinhiberende forbindelse ved administrering av mat og/eller ritonavir eller et farmasøytisk akseptabelt salt derav sammen med HIV-integraseinhibitoren.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75503905P | 2005-12-30 | 2005-12-30 | |
US75663106P | 2006-01-06 | 2006-01-06 | |
US76390106P | 2006-02-01 | 2006-02-01 | |
PCT/US2006/049668 WO2007079260A1 (en) | 2005-12-30 | 2006-12-29 | Methods for improving the pharmacokinetics of hiv integrase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083333L true NO20083333L (no) | 2008-09-29 |
Family
ID=38016698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20083333A NO20083333L (no) | 2005-12-30 | 2008-07-29 | Fremgangsmater for forbedring av farmakokinetikken til HIV-integraseinhibitorer |
Country Status (16)
Country | Link |
---|---|
US (1) | US20070219243A1 (no) |
EP (2) | EP2308490A1 (no) |
JP (1) | JP4676536B2 (no) |
KR (3) | KR101524165B1 (no) |
CN (1) | CN104069108A (no) |
AP (1) | AP2702A (no) |
AU (1) | AU2006332664B2 (no) |
BR (1) | BRPI0620865A2 (no) |
CA (2) | CA2635468C (no) |
EA (2) | EA201201496A1 (no) |
HR (1) | HRP20080313A2 (no) |
IL (1) | IL192208A (no) |
NO (1) | NO20083333L (no) |
NZ (1) | NZ569576A (no) |
SG (2) | SG170796A1 (no) |
WO (1) | WO2007079260A1 (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090233964A1 (en) * | 2005-12-30 | 2009-09-17 | Gilead Sciences, Inc. | Methods for improving the pharmacokinetics of hiv integrase inhibitors |
MX2009008935A (es) | 2007-02-23 | 2009-11-02 | Gilead Sciences Inc | Moduladores de las propiedades farmacocineticas de productos terapeuticos. |
KR20100028656A (ko) * | 2007-06-29 | 2010-03-12 | 길리애드 사이언시즈, 인코포레이티드 | 치료 조성물 및 그의 용도 |
AR067183A1 (es) * | 2007-06-29 | 2009-09-30 | Gilead Sciences Inc | Composiciones terapeuticas y metodos, usos y equipos |
US20110117193A1 (en) * | 2008-01-17 | 2011-05-19 | Duquesne University Of The Holy Spirit | Antiretroviral drug formulations for treatment of children exposed to hiv/aids |
AP3551A (en) | 2010-01-27 | 2016-01-18 | Viiv Healthcare Co | Antiviral therapy |
WO2013109354A2 (en) * | 2011-12-07 | 2013-07-25 | Texas Southern University | Etravirine formulations and uses thereof |
CA3012242C (en) | 2012-12-21 | 2021-11-02 | Gilead Sciences, Inc. | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use |
NO2865735T3 (no) | 2013-07-12 | 2018-07-21 | ||
JP6411491B2 (ja) | 2013-07-12 | 2018-10-24 | ギリアード サイエンシス インコーポレーテッド | 多環式カルバモイルピリドン化合物およびhiv感染症を処置するためのその使用 |
TW201613936A (en) | 2014-06-20 | 2016-04-16 | Gilead Sciences Inc | Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide |
TWI744723B (zh) | 2014-06-20 | 2021-11-01 | 美商基利科學股份有限公司 | 多環型胺甲醯基吡啶酮化合物之合成 |
NO2717902T3 (no) | 2014-06-20 | 2018-06-23 | ||
TWI738321B (zh) | 2014-12-23 | 2021-09-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
SG11201705069YA (en) | 2014-12-26 | 2017-07-28 | Univ Emory | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
AU2016244035B2 (en) | 2015-04-02 | 2018-11-01 | Gilead Sciences, Inc. | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use |
EP3632415A1 (en) | 2015-11-09 | 2020-04-08 | Gilead Sciences, Inc. | Therapeutic compositions for treatment of human immunodeficiency virus |
EP3706762A4 (en) | 2017-12-07 | 2021-09-01 | Emory University | N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTIVIRAL USES IN RELATION TO IT |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5539122A (en) | 1989-05-23 | 1996-07-23 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US5354866A (en) | 1989-05-23 | 1994-10-11 | Abbott Laboratories | Retroviral protease inhibiting compounds |
DK0727419T3 (da) | 1992-12-29 | 2002-06-10 | Abbott Lab | Mellemprodukter til fremstilling af forbindelser, som inhiberer retroviral protease |
US5567823A (en) | 1995-06-06 | 1996-10-22 | Abbott Laboratories | Process for the preparation of an HIV protease inhibiting compound |
US6037157A (en) | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
MXPA01012478A (es) * | 1999-06-04 | 2003-10-14 | Abbott Lab | Formulaciones farmaceuticas mejoradas. |
US6541515B2 (en) * | 2000-08-09 | 2003-04-01 | Merck & Co., Inc. | HIV integrase inhibitors |
US6407128B1 (en) * | 2001-12-03 | 2002-06-18 | Elan Pharmaceuticals, Inc. | Method for increasing the bioavailability of metaxalone |
TWI286476B (en) * | 2001-12-12 | 2007-09-11 | Tibotec Pharm Ltd | Combination of cytochrome P450 dependent protease inhibitors |
AU2003301439A1 (en) * | 2002-10-16 | 2004-05-04 | Gilead Sciences, Inc. | Pre-organized tricyclic integrase inhibitor compounds |
CZ2004764A3 (cs) * | 2002-11-20 | 2005-02-16 | Japan Tobacco Inc | 4-Oxochinolinová sloučenina a její použití jako inhibitoru HIV-integrázy |
JP3567162B1 (ja) * | 2002-11-20 | 2004-09-22 | 日本たばこ産業株式会社 | 4−オキソキノリン化合物及びそのhivインテグラーゼ阻害剤としての利用 |
BRPI0407052A (pt) | 2003-01-27 | 2006-01-17 | Pfizer | Inibidores da hiv-integrase, composições farmacêuticas, e métodos para sua utilização |
WO2004101512A2 (en) * | 2003-05-13 | 2004-11-25 | Smithkline Beecham Corporation | Naphthyridine integrase inhibitors |
MY134672A (en) * | 2004-05-20 | 2007-12-31 | Japan Tobacco Inc | Stable crystal of 4-oxoquinoline compound |
US7531554B2 (en) * | 2004-05-20 | 2009-05-12 | Japan Tobacco Inc. | 4-oxoquinoline compound and use thereof as HIV integrase inhibitor |
WO2005112930A1 (en) * | 2004-05-21 | 2005-12-01 | Japan Tobacco Inc. | Combinations comprising a 4-isoquinolone derivative and anti-hiv agents |
US8119602B2 (en) * | 2005-06-02 | 2012-02-21 | Schering Corporation | Administration of HCV protease inhibitors in combination with food to improve bioavailability |
US20090233964A1 (en) * | 2005-12-30 | 2009-09-17 | Gilead Sciences, Inc. | Methods for improving the pharmacokinetics of hiv integrase inhibitors |
BRPI0716752A2 (pt) * | 2006-09-12 | 2013-09-17 | Gilead Sciences Inc | processo e intermediÁrios para preparo de inibidores de intergrase |
AR067183A1 (es) * | 2007-06-29 | 2009-09-30 | Gilead Sciences Inc | Composiciones terapeuticas y metodos, usos y equipos |
KR20100028656A (ko) * | 2007-06-29 | 2010-03-12 | 길리애드 사이언시즈, 인코포레이티드 | 치료 조성물 및 그의 용도 |
AR068403A1 (es) * | 2007-09-11 | 2009-11-18 | Gilead Sciences Inc | Proceso e intermediarios para la preparacion de inhibidores de integrasa |
-
2006
- 2006-12-29 SG SG201102229-0A patent/SG170796A1/en unknown
- 2006-12-29 KR KR1020087018651A patent/KR101524165B1/ko active IP Right Grant
- 2006-12-29 AP AP2008004522A patent/AP2702A/xx active
- 2006-12-29 CN CN201410249622.8A patent/CN104069108A/zh active Pending
- 2006-12-29 CA CA2635468A patent/CA2635468C/en active Active
- 2006-12-29 EP EP20100193364 patent/EP2308490A1/en not_active Withdrawn
- 2006-12-29 CA CA2847871A patent/CA2847871C/en active Active
- 2006-12-29 JP JP2008548784A patent/JP4676536B2/ja active Active
- 2006-12-29 SG SG201102227-4A patent/SG170795A1/en unknown
- 2006-12-29 KR KR1020147014797A patent/KR20140082858A/ko not_active Application Discontinuation
- 2006-12-29 EA EA201201496A patent/EA201201496A1/ru unknown
- 2006-12-29 EP EP06848393A patent/EP1976517A1/en not_active Withdrawn
- 2006-12-29 EA EA200801619A patent/EA018544B1/ru unknown
- 2006-12-29 WO PCT/US2006/049668 patent/WO2007079260A1/en active Application Filing
- 2006-12-29 US US11/647,858 patent/US20070219243A1/en not_active Abandoned
- 2006-12-29 NZ NZ569576A patent/NZ569576A/en unknown
- 2006-12-29 BR BRPI0620865-7A patent/BRPI0620865A2/pt not_active IP Right Cessation
- 2006-12-29 KR KR1020167016288A patent/KR20160074018A/ko not_active Application Discontinuation
- 2006-12-29 AU AU2006332664A patent/AU2006332664B2/en active Active
-
2008
- 2008-06-16 IL IL192208A patent/IL192208A/en active IP Right Grant
- 2008-07-01 HR HR20080313A patent/HRP20080313A2/xx not_active Application Discontinuation
- 2008-07-29 NO NO20083333A patent/NO20083333L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007079260A1 (en) | 2007-07-12 |
CN104069108A (zh) | 2014-10-01 |
US20070219243A1 (en) | 2007-09-20 |
CA2635468A1 (en) | 2007-07-12 |
AP2702A (en) | 2013-07-23 |
KR20160074018A (ko) | 2016-06-27 |
IL192208A (en) | 2013-10-31 |
SG170796A1 (en) | 2011-05-30 |
WO2007079260A9 (en) | 2007-08-30 |
AU2006332664A1 (en) | 2007-07-12 |
AU2006332664B2 (en) | 2013-03-14 |
IL192208A0 (en) | 2009-02-11 |
CA2635468C (en) | 2016-08-09 |
JP4676536B2 (ja) | 2011-04-27 |
EP2308490A1 (en) | 2011-04-13 |
CA2847871A1 (en) | 2007-07-12 |
HRP20080313A2 (en) | 2008-11-30 |
KR20140082858A (ko) | 2014-07-02 |
JP2009525265A (ja) | 2009-07-09 |
CA2847871C (en) | 2016-07-26 |
KR20080081358A (ko) | 2008-09-09 |
AP2008004522A0 (en) | 2008-06-30 |
BRPI0620865A2 (pt) | 2011-11-29 |
EP1976517A1 (en) | 2008-10-08 |
EA018544B1 (ru) | 2013-08-30 |
SG170795A1 (en) | 2011-05-30 |
NZ569576A (en) | 2011-09-30 |
KR101524165B1 (ko) | 2015-06-01 |
EA201201496A1 (ru) | 2013-07-30 |
EA200801619A1 (ru) | 2008-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20083333L (no) | Fremgangsmater for forbedring av farmakokinetikken til HIV-integraseinhibitorer | |
NO20063958L (no) | HIV integrase inhibitorer | |
BRPI1011838A2 (pt) | composto de carboxamida heterocíclica de diamino | |
ATE518844T1 (de) | Kaliumsalz eines hiv-integrase-inhibitors | |
CL2007003100A1 (es) | Compuestos derivados de pirimidina, inhibidores de cisteina proteasa; procesos de preparacion; sales de los compuestos; composicion farmaceutica; y uso para el tratamiento de la malaria. | |
CL2007003594A1 (es) | Compuestos derivados de heterociclos condensados de nitrogeno, inhibidores de transcriptasa inversa no nucleosidicos; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del sida. | |
ATE461202T1 (de) | Hiv-integrasehemmer | |
NO20070751L (no) | Inhibitorer av HCV-replifikasjon | |
WO2006130686A3 (en) | Hcv protease inhibitors in combination with food | |
EA200801199A1 (ru) | Ингибиторы киназы | |
WO2005115398A3 (en) | Hiv integrase inhibitors | |
MY154898A (en) | P70 s6 kinase inhibitors | |
TW200736229A (en) | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors | |
WO2004073623A3 (en) | Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions | |
WO2003065987A3 (en) | Granzyme b inhibitors | |
NO20073370L (no) | Kombinasjoner som innbefatter epotiloner og proteintyrosinkinaseinhibitorer og farmasoytiske anvendelser derav | |
CL2007003540A1 (es) | Compuestos derivados de macrociclos, inhibidores de la proteasa serina de hepatitis c; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c. | |
WO2011113060A3 (en) | Antiviral compounds and methods of use thereof | |
ATE554084T1 (de) | N-hydroxyacrylamidverbindungen | |
WO2007019098A3 (en) | Hiv integrase inhibitors | |
CY1112451T1 (el) | Μεθοδος για μειωση γαστρεντερικης τοξικοτητας λογω της χορηγησης τεγκαφουρης | |
BRPI0516128A (pt) | uso de inibidores de renina para a prevenção ou tratamento de disfunção diastólica ou insuficiência cardìca diastólica | |
WO2008048121A3 (en) | Macrocyclic cysteine protease inhibitors and compositions thereof | |
WO2007044325A3 (en) | Apoe4 domain interaction inhibitors and methods of use thereof | |
WO2009106599A3 (en) | Substituted piperidines as therapeutic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |